The risk of ultraviolet exposure for melanoma in Fitzpatrick skin types I-IV: A 20-year systematic review with meta-analysis for sunburns.

J Eur Acad Dermatol Venereol

Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.

Published: September 2024

AI Article Synopsis

  • A systematic review was conducted to analyze the relationship between different types of ultraviolet (UV) exposure and the risk of melanoma in individuals with Fitzpatrick skin types I-IV over the past 20 years.
  • Out of nearly 20,000 studies, 26 were included, and a significant association between UV exposure and melanoma was found in 77% of these studies, particularly highlighting sunburn as a key risk factor.
  • The research indicates that UV exposure remains a critical modifiable risk factor for melanoma in fair-skinned individuals, with specific odds ratios demonstrating the increased risk associated with sunburn and cumulative sun exposure.

Article Abstract

Within the last two decades, no studies have comprehensively reviewed the risk of varying types of ultraviolet (UV) exposure on melanoma in fairer skinned individuals. Our research objective was to determine whether or not there was a change in the risk of UV exposure with development of melanoma in Fitzpatrick skin types I-IV based on more recent data over the past 20 years. We performed a systematic review from January 2002 to December 2021 analysing UV exposure and melanoma risk in Fitzpatrick type I-IV individuals. Out of 19,852 studies, 26 met inclusion criteria. Data spanned subjects from national and multinational cohorts (USA, Europe, Australia, Asia and South America). Twenty studies (77%, 20/26) identified a significant association between UV exposure and melanoma incidence. Sunburn was the most commonly assessed risk factor. Sunburn studies encompassed 3417 melanoma and found positive significant odds ratios (OR [95% CI]) in 11 out of 13 studies, ranging from 1.23 [1.01-1.49] to 8.48 [4.35-16.54]. Pooled analysis of the risk of melanoma with sunburn history found an unadjusted odds ratio of 1.66 [1.40-1.97] and adjusted odds ratio of 1.23 [1.04-1.46]. Cumulative sun exposure, measured as number of hours of sun exposure or calculated UV flux, was the second most common risk factor, encompassing 913 melanomas with positive significant ORs ranging from 1.1 [1.0-1.2] to 5.2 [2.1-12.5]. For other forms of UV exposure, a majority of studies showed an association with UV index (6/9), outdoor leisure activity (3/3) and left-sided laterality (1/1). Overall, UV exposure should continue to be considered a modifiable risk factor for melanoma in individuals of fairer skin.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jdv.20316DOI Listing

Publication Analysis

Top Keywords

exposure melanoma
16
risk factor
12
exposure
9
risk
8
ultraviolet exposure
8
melanoma
8
melanoma fitzpatrick
8
fitzpatrick skin
8
skin types
8
types i-iv
8

Similar Publications

[Ophthalmic oncology in a warmer world: climate-related increase in the prevalence of eyelid cancer].

Ophthalmologie

January 2025

Klinik für Augenheilkunde, Klinikum Chemnitz, Flemmingstr. 2, 09116, Chemnitz, Deutschland.

Background: Damage induced by ultraviolet (UV) radiation plays a decisive role in the carcinogenesis of malignant tumors of the eyelids.

Methods: A selective literature search was performed in PubMed and Google Scholar.

Results: Large epidemiological studies show an increase in the prevalence of eyelid tumors in recent decades.

View Article and Find Full Text PDF

Background: Cancer treatments are still limited by various challenges, such as off-target drug delivery, posttreatment inflammation, and the hypoxic conditions in the tumor microenvironment; thus, the development of effective therapeutics remains highly desirable. Exosomes are extracellular vesicles with a size of 30-200 nm that have been widely applied as drug carriers over the last decade. In this study, melanoma-derived exosomes were used to develop a perfluorocarbon (PFC) drug nanocarriers loaded with indocyanine green (ICG) and camptothecin (CPT) (ICFESs) for targeted cancer photochemotherapy.

View Article and Find Full Text PDF

Immune checkpoint inhibitor-associated gastrointestinal adverse events in patients with colorectal cancer.

Ann Gastroenterol

December 2024

Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (Saltenat Moghaddam Adames, Malek Shatila, Yinghong Wang, Anusha Thomas).

Background: Immune checkpoint inhibitors (ICI) target microsatellite instability-high (MSI-H) tumors with success. The incidence and characteristics of ICI-related colitis (IMC) in patients with MSI-H colorectal cancers (CRC) are unclear.

Methods: We performed a retrospective analysis of adult patients with CRC who received ICI between June 1, 2014, and December 31, 2022, including data on IMC observed up to 3 months after the last dose of ICI.

View Article and Find Full Text PDF

Background: The use of immune checkpoint inhibitors (CPIs) has become a dominant regimen in modern cancer therapy, however immune resistance induced by tumor-associated macrophages (TAMs) with immune suppressive and evasion properties limits responses. Therefore, the rational design of immune modulators that can control the immune suppressive properties of TAMs and polarize them, as well as dendritic cells (DCs), toward a more proinflammatory phenotype is a principal objective in cancer immunotherapy.

Methods: Here, using a protein engineering approach to enhance cytokine residence in the tumor microenvironment, we examined combined stimulation of the myeloid compartment via tumor stroma-binding granulocyte-macrophage colony-stimulating factor (GM-CSF) to enhance responses in both DCs and T cells via stroma-binding interleukin-12 (IL-12).

View Article and Find Full Text PDF

Background: Although ultraviolet radiation is the most important risk factor for skin cancer in general, its role in disease control after the diagnosis of melanoma remains to be elucidated.

Objectives: To analyse the association between survival and self-assessed sun protection behaviour after a melanoma diagnosis.

Methods: This was a questionnaire-based pilot study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!